Market Research Logo

Exiqon AS - Product Pipeline Analysis, 2017 Update

Summary

Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products. Its microRNA research products comprise RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits, and functional analysis. Exiqon offers services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service. The company’s products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection. It operates in Denmark and the US. Exiqon is headquartered in Vedbaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and Recent Developments
  • The report analyzes all pipeline products in development for the company Exiqon AS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Exiqon A/S Company Overview 4
Exiqon A/S Company Snapshot 4
Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview 4
Exiqon A/S – Pipeline Analysis Overview 7
Exiqon A/S - Key Facts 7
Exiqon A/S - Major Products and Services 8
Exiqon A/S Pipeline Products by Development Stage 9
Exiqon A/S Pipeline Products Overview 11
Colon Cancer Test - Stage III And IV Patient 11
Colon Cancer Test - Stage III And IV Patient Product Overview 11
Diagnostic Test - Prostate Cancer Stratification 12
Diagnostic Test - Prostate Cancer Stratification Product Overview 12
Diagnostic Test - T-Cell Lymphoma 13
Diagnostic Test - T-Cell Lymphoma Product Overview 13
Genetic Test - Prostate Cancer 14
Genetic Test - Prostate Cancer Product Overview 14
miRNA Biomarker - Cancer of Unknown Primary 15
miRNA Biomarker - Cancer of Unknown Primary Product Overview 15
miRNA Test - Endometrial Cancer 16
miRNA Test - Endometrial Cancer Product Overview 16
miRNA Test - Lung Cancer 17
miRNA Test - Lung Cancer Product Overview 17
miRNA test - Ovarian Cancer 18
miRNA test - Ovarian Cancer Product Overview 18
Prognosis Test - Prostate Cancer 19
Prognosis Test - Prostate Cancer Product Overview 19
Prostate Cancer - Early Detection Test 20
Prostate Cancer - Early Detection Test Product Overview 20
Exiqon A/S - Key Competitors 21
Exiqon A/S - Key Employees 22
Exiqon A/S - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Exiqon A/S, Recent Developments 24
Jul 13, 2016: Nasdaq Copenhagen accepts Exiqon request for delisting and cancellation from trading of the Exiqon shares 24
Jul 04, 2016: Exiqon – Nomination of candidates for the supervisory board 24
Apr 26, 2016: Exiqon: First Quarter 2016 Supports Continued Strong Momentum 24
Feb 08, 2016: Exiqon realizes full year 2015 profitability driven by strong revenue growth 25
Nov 06, 2015: Accelerated RNA discovery by XploreRNA presented to audience at Genome Festival 25
Oct 26, 2015: Third consecutive profitable quarter with continued strong growth 26
Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability 26
Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA 27
Jun 30, 2015: Exiqon launches ExiLERATE LNA qPCR product portfolio for analysis of mRNA and lncRNA 28
Dec 18, 2014: Exiqon launches new Research Use Only kit for PCR analysis of colon cancer samples 28
Appendix 29
Methodology 29
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview 4
Exiqon A/S Pipeline Products by Equipment Type 5
Exiqon A/S Pipeline Products by Indication 6
Exiqon A/S, Key Facts 7
Exiqon A/S, Major Products and Services 8
Exiqon A/S Number of Pipeline Products by Development Stage 9
Exiqon A/S Pipeline Products Summary by Development Stage 10
Colon Cancer Test - Stage III And IV Patient - Product Status 11
Colon Cancer Test - Stage III And IV Patient - Product Description 11
Diagnostic Test - Prostate Cancer Stratification - Product Status 12
Diagnostic Test - Prostate Cancer Stratification - Product Description 12
Diagnostic Test - T-Cell Lymphoma - Product Status 13
Diagnostic Test - T-Cell Lymphoma - Product Description 13
Genetic Test - Prostate Cancer - Product Status 14
Genetic Test - Prostate Cancer - Product Description 14
miRNA Biomarker - Cancer of Unknown Primary - Product Status 15
miRNA Biomarker - Cancer of Unknown Primary - Product Description 15
miRNA Test - Endometrial Cancer - Product Status 16
miRNA Test - Endometrial Cancer - Product Description 16
miRNA Test - Lung Cancer - Product Status 17
miRNA Test - Lung Cancer - Product Description 17
miRNA test - Ovarian Cancer - Product Status 18
miRNA test - Ovarian Cancer - Product Description 18
Prognosis Test - Prostate Cancer - Product Status 19
Prognosis Test - Prostate Cancer - Product Description 19
Prostate Cancer - Early Detection Test - Product Status 20
Prostate Cancer - Early Detection Test - Product Description 20
Exiqon A/S, Key Employees 22
Exiqon A/S, Subsidiaries 23
Glossary 30
List of Figuress
Exiqon A/S Pipeline Products by Equipment Type
Exiqon A/S Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report